Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

98 results found in London, UK

Sort by:
Showing 21 - 30 of 98 results
Dr Naomi Fersht

Dr Naomi Fersht

1.28 miles

Dr Naomi Fersht

1.28 miles
Expert in: Oncology
25 years of experience

Dr Naomi Fersht is a consultant clinical oncologist at University College Hospital and the National Hospital for Neurology and Neurosurgery. She specialises exclusively in the management of primary and secondary brain and spinal tumours. This involves the use of both conventional and innovative radiotherapy techniques and chemotherapy.

Her special interests are brain oligometastases; meningiomas; pituitary tumours; the management of teenagers and young adults with brain tumours; and advanced radiotherapy techniques including radiosurgery.

She qualified from the University of Cambridge and her specialist training was at the Royal Marsden and University College Hospitals. Naomi's doctoral thesis, supervised by Nobel Laureate Sir Paul Nurse, was in cell cycle checkpoints.

Read more
Expert in: Oncology
28 years of experience
Clinical Oncology

Professor Elinor Sawyer is a Consultant Clinical Oncologist with a specialist interest in the treatment of breast cancer. She is based at Guy’s & St Thomas’ Hospital but also performs private work and is Professor in Oncology at King’s College London.

She completed her clinical oncology training at University College London, Royal Free and St Thomas’ Hospitals. Following this, she obtained her PhD in molecular genetics of cancer at the London Research Institute. In 2005 she was appointed as a Consultant Oncologist at Guy’s & St Thomas’ Hospital.


As well as her clinical practice, Professor Sawyer is heavily involved in research and her work has been published in a number of peer reviewed journals. Her main areas of research include genetic predisposition to breast cancer, particularly lobular breast cancer and pre invasive cancer (DCIS and LCIS), and identification of biomarkers that predict progression of early breast cancer.

Read more
Expert in: Oncology
24 years of experience
Clinical Oncology

Dr Stephen Morris is a consultant in Clinical Oncology at Guy's and St Thomas' Hospitals, specialising in the management of skin and urological cancers. He specialises in brachytherapy, external beam radiotherapy and chemotherapy for prostate cancer at Guys Hospital. He also leads the chemotherapy and radiotherapy service for cutaneous lymphoma at the St Johns Institute of dermatology at Guys.

Dr Morris graduated from Guy's and St Thomas' medical school, training in clinical oncology at the Royal Marsden Hospital and the Guy's and St Thomas' Cancer Centre. At Guys he was involved in setting up the dynamic prostate brachytherapy service and since his appointment as a consultant, has continued to innovate in the field. As well as research and clinical trials, he has led the design and implementation of a new modern Total Skin Electron Beam technique for cutaneous lymphoma, IMRT and IGRT for prostate cancer and more recently has developed and implemented the use of the SpaceOAR and Auto Beam Hold intra fraction IGRT technique for prostate cancer. Dr Morris is also involved in education as a tutor for clinical oncology.

Read more
Expert in: Oncology
29 years of experience
Clinical Oncology

Professor Andrew Tutt is a Consultant Clinical Oncologist specialising in breast cancer. He is based at Guy’s Hospital Breast Unit but also performs private work and is a Professor of Oncology at King’s College London School of Medicine.

He qualified in medicine in 1990 and went on to complete his postgraduate training at a number of hospitals around the UK. After completing his clinical oncology training at the Royal Marsden Hospital London, he was awarded a Doctoral Research Training Fellowship at The Institute of Cancer Research, London, where he gained his PhD in cancer biology.

Professor Tutt is actively involved in clinical research and has published a number of breast cancer research papers. His main areas of research include the ‘triple negative’ and BRCA1 and BRCA2 associated breast cancers. He has led a number of international trials of drug therapies and research programmes in these areas.

He is often asked to speak at major European and North American Cancer Medicine conferences. He is a member of the St Gallen International Breast Cancer Consensus Panel that develops guidelines for the treatment of breast cancer. He is also part of a UK team that trial new techniques in breast radiotherapy.

Read more
Expert in: Oncology
21 years of experience
Medical Oncology

Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies including lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award for his work on Acute Diagnostic Oncology Clinics.

He completed his training at University College and Middlesex School of Medicine in London, and graduated in anatomy and medicine in 1998. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals in London. During this time he also completed his Cancer Research funded PhD in tumour immunology. Following this he became a Clinical Lecturer in medical oncology at Imperial College London, supported by the Wellcome Trust and Academy of Medical Sciences.

Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital and is also the Vice Chair of the British Thoracic Oncology Group Steering Committee. He has also served two terms on the National Cancer Research Institutes lung cancer group and previously led the RM Partners Cancer Vanguard which represents 3.5m patients in South and West London.

He is also actively involved in clinical trials and research, and has been invited to present his work at a number of national and international meetings. He has given lectures for a number of organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

Read more
Expert in: Oncology
19 years of experience
Clinical Oncology

Dr Tom Richards is a consultant clinical oncologist specialising in the treatment of gastrointestinal (GI) and breast cancers. He is the clinical lead of the GI and breast cancer radiotherapy units at University College London NHS Hospital (UCLH) and honorary consultant in Clinical Oncology at The Whittington NHS Hospital. Prior to his appointment at UCLH, he was Clinical Oncology consultant in the GI and breast units at St Bartholomew's and The Royal London NHS Hospitals.

He is an experienced oncologist treating oesophagus, stomach, liver, pancreaticobiliary, colorectal and breast cancers. His specialist expertise is the delivery of radiotherapy, chemotherapy and biological targeted drugs for cancers at these sites. His particular interest is in technical radiotherapy treatments using cyberknife and intensity-modulated radiotherapy and motion management techniques using 4D-CT radiotherapy planning, deep inspiratory breath-hold and image-guided radiotherapy.

After graduation from Imperial College School of Medicine in London, his subsequent general internal medicine training was at King's College Hospital, London. He undertook specialist oncology training at St Bartholomew's and The Royal Marsden Hospitals in London. In 2015 he was awarded a PhD from the University of London for clinical and translation research performed at The Institute of Cancer Research, King's College London and The Royal Marsden Hospital. He studied the mechanisms by which therapeutic radiation affects normal tissues and strategies to detect and reduce late toxicity after curative treatment. He was awarded the Johnson and Johnson clinical research prize in 2012 for work contributing to his PhD.

He is a fellow of the Royal College of Radiologists and a member of The Royal College of Physicians, ESMO and ESTRO. He has spoken and chaired sessions at numerous national and international meetings. He is course tutor and examiner for the Institute of Cancer research MSc course and is the local principal investigator for several GI cancer clinical trials. Dr Richards is passionate to improve cancer outcomes, develop clinical research and deliver innovative multi-modality cancer treatments.

Read more
Expert in: Oncology
17 years of experience

Dr Hadaki is an experienced Consultant Oncologist who treats all stages of breast cancer.

He completed his specialist oncology training at Addenbrooke’s Teaching Hospital which has strong affiliations to the University of Cambridge. During his training, he completed the Royal College of Radiologist membership exam to proudly become one of its fellowships.

Dr Hadaki has been practising as a consultant since 2012 and has a very successful private practise in addition to his large well-established NHS practice.

Dr Hadaki is skillfully able to combine (where appropriate) the following treatment modalities to offer a complete and state of the art personalised cancer treatment service:

  • Chemotherapy
  • External beam radiotherapy (including IMRT and IGRT)
  • Biological and targeted therapies
  • Immunotherapies
  • Stereotactic radiotherapy (SBRT, SABR, Cyberknife)
  • Next-generation sequencing and molecular analysis of tumours
  • Chemotherapy sensitivity testing
  • Access to clinical trials
  • Access to local ablative therapies (radiofrequency ablation, microwave ablation)
  • Access to alternative therapies
  • Access to palliative care services

Dr Hadaki also works with some of the most skilled surgeons in the country. All treatment plans are discussed at multidisciplinary team meetings.

Dr Hadaki is registered and compliant with the majority of private medical insurers including BUPA, BUPA International, AXA, Aviva, Vitality, WPA and others.

Dr Hadaki is able to treat international and self-paying patients. Embassy sponsored patients must have a letter of guarantee before any consultation or commencing treatment.

Self-paying patients should contact us directly for a quotation.

Read more
Expert in: Oncology
27 years of experience

Professor Christopher Nutting is a Consultant Clinical Oncologist based at The Royal Marsden Chelsea and Sutton, where he has both a private and NHS practice. 

Professor Nutting completed his undergraduate training at the University of London in 1992 and he went on to become a member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists. Professor Nutting qualified as an oncologist and achieved a Medical Doctorate at The Institute of Cancer Research, University of London.

Professor Nutting has a special interest in medical education and in 2001 he was appointed Honorary Senior Lecturer in Clinical Oncology at The Institute of Cancer Research. In 2002 he assumed the role of Teacher at the University of London and Head of the Head and Neck Unit at The Royal Marsden.

Professor Nutting is National Clinical Lead in Head and Neck Cancer for the UK Department of Health and the Cancer Services Collaborative. He is also President of the British Oncological Association and Chairman of the National Cancer Research Institute Committee for Head and Neck Cancer Research.

Professor Nutting is heavily involved in research trials and he has published over 300 research articles in his speciality.

 

Read more
Expert in: Oncology
Recommended by 1 specialist
21 years of experience
Medical Oncology

Dr Kristeleit completed his undergraduate studies at the Universities of Bonn (Germany), Lausanne (Switzerland) and Barts and The London School of Medicine. He has a first class medical degree from Bonn University and performed his post graduate and specialist training in London teaching hospitals. He spent four years as an AVON Clinical Research Fellow at the Breakthrough Breast Cancer Research Centre investigating novel targets in familial breast cancer. He was appointed as a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust in 2009.

He has a special interest in breast cancer and Acute Oncology. He provides the medical oncology service for breast cancer at Queen Elizabeth and Queen Mary's hospitals and is currently the lead clinician for Acute Oncology in the South East London Accountable Cancer Network. Dr Kristeleit has a keen research interest in the role of novel therapies for breast cancer. He is an investigator on numerous clinical trials for breast cancer and chairs the oncology research committee at Guy's and St Thomas'.

He gives regular lectures for the University of London and has been invited to speak at national conferences and international meetings. He specializes in the treatment of early and advanced breast cancer.

Read more
Expert in: Oncology
30 years of experience

Dr Gregory Wilson is a Consultant Medical Oncologist, based in Manchester at The Christie NHS Foundation Trust. Dr Wilson also sees patients privately at a range of centres, both in the north west and in London. His interests include breast and colorectal cancer and he has a particular focus on metastatic diseases and patients with liver metastases. Dr Wilson is the Lead Clinician for liver-directed therapies and he provides The Harley Street Clinic with both an advisory and visiting clinical service. He works closely with consultant oncology, surgery and radiology colleagues to provide liver-directed therapies for patients of the Harley Street Clinic and The London Oncology Clinic.

He advises on a range of treatment options including Selective Internal Radiation Therapy, Chemotherapy Saturation of the liver and DC beads, a novel drug delivery embolisation system for tumours in the liver. Dr Wilson is a member of the breast and gastrointestinal disease groups of The Christie Hospital and takes an active role in recruiting patients onto national and international clinical research trials of newer treatment regimes.

 

 

 

Read more